Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism GDF15 agonists(Growth/differentiation factor 15 agonists), GLP-1R agonists(Glucagon-like peptide 1 receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetes Mellitus, Type 2 | Preclinical | KR | 02 Nov 2023 | |
Obesity | Preclinical | KR | 02 Nov 2023 |